Pan-cancer analysis identifies ADAM12 as a prognostic biomarker and indicator of immune infiltration in glioma
Abstract ADAM12, part of the adisintegrin and metalloproteases (ADAMs) family, has been widely reported in recent years to be associated with various malignant tumor behaviors, including migration, invasion, and treatment resistance. However, its role at the pan-cancer level remains insufficiently c...
Saved in:
| Main Authors: | Peng Lv, Yanbin Zhang, Wenjie Wu, Xiaobing Jiang, Wei Xiang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-02-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-90121-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pan-cancer analysis identifies CLEC12A as a potential biomarker and therapeutic target for lung adenocarcinoma
by: Desheng Zhou, et al.
Published: (2025-04-01) -
EFNB1 drives glioma progression and shapes the immune microenvironment: a potential prognostic biomarker
by: Yungui Zheng, et al.
Published: (2025-02-01) -
Emerging roles of ADAM6 and PRSS1 as novel diagnostic/prognostic biomarkers for acute lymphoblastic and myeloid leukemia in adults
by: Heba M. Anis, et al.
Published: (2025-05-01) -
Metabolism-Related Genes SMOX and SUCLG2 as Immunological and Prognostic Biomarkers in Colorectal Cancer: A Pan-Cancer Analysis
by: Zuming Xiong, et al.
Published: (2025-06-01) -
Characterization of lysine crotonylation-related lncRNAs for prognostic assessment and immune response in glioma
by: Miaomiao Song, et al.
Published: (2025-06-01)